ArticleScientific reports2019

CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma.

Jakob Nikolas Kather et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.